GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 62 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,728,360 | +33.3% | 1,941,854 | 0.0% | 0.00% | – |
| Q2 2023 | $2,796,270 | -31.4% | 1,941,854 | 0.0% | 0.00% | – |
| Q1 2023 | $4,077,893 | +85.8% | 1,941,854 | 0.0% | 0.00% | – |
| Q4 2022 | $2,194,295 | -30.6% | 1,941,854 | +0.1% | 0.00% | – |
| Q3 2022 | $3,163,000 | +24.4% | 1,940,807 | 0.0% | 0.00% | – |
| Q2 2022 | $2,543,000 | -18.6% | 1,940,807 | 0.0% | 0.00% | – |
| Q1 2022 | $3,125,000 | -22.6% | 1,940,807 | -0.5% | 0.00% | – |
| Q4 2021 | $4,037,000 | -46.7% | 1,950,688 | -0.1% | 0.00% | – |
| Q3 2021 | $7,579,000 | +21.2% | 1,953,419 | 0.0% | 0.00% | – |
| Q2 2021 | $6,252,000 | +49.1% | 1,953,419 | +1.1% | 0.00% | – |
| Q1 2021 | $4,194,000 | -0.4% | 1,932,309 | +2.8% | 0.00% | – |
| Q4 2020 | $4,212,000 | -14.7% | 1,880,527 | +1.7% | 0.00% | – |
| Q3 2020 | $4,937,000 | -13.4% | 1,849,428 | -0.8% | 0.00% | – |
| Q2 2020 | $5,703,000 | +58.5% | 1,863,580 | +1.5% | 0.00% | – |
| Q1 2020 | $3,597,000 | -31.6% | 1,835,500 | -0.1% | 0.00% | – |
| Q4 2019 | $5,255,000 | -21.1% | 1,837,365 | +1.3% | 0.00% | – |
| Q3 2019 | $6,659,000 | -7.5% | 1,814,462 | +4.6% | 0.00% | – |
| Q2 2019 | $7,197,000 | -12.5% | 1,734,324 | +7.8% | 0.00% | – |
| Q1 2019 | $8,223,000 | +67.3% | 1,609,232 | +12.3% | 0.00% | – |
| Q4 2018 | $4,914,000 | -42.9% | 1,432,576 | 0.0% | 0.00% | – |
| Q3 2018 | $8,609,000 | +12.2% | 1,432,576 | +18.7% | 0.00% | – |
| Q2 2018 | $7,675,000 | +38.8% | 1,206,754 | +3.5% | 0.00% | – |
| Q1 2018 | $5,529,000 | +80.9% | 1,166,313 | +27.5% | 0.00% | – |
| Q4 2017 | $3,056,000 | +69.4% | 915,023 | +7.5% | 0.00% | – |
| Q3 2017 | $1,804,000 | -15.9% | 850,948 | -2.4% | 0.00% | – |
| Q2 2017 | $2,144,000 | +26.4% | 871,510 | +18.2% | 0.00% | – |
| Q1 2017 | $1,696,000 | +228.7% | 737,345 | +40.0% | 0.00% | – |
| Q4 2016 | $516,000 | -22.6% | 526,841 | -10.6% | 0.00% | – |
| Q3 2016 | $667,000 | -25.2% | 589,523 | -2.8% | 0.00% | – |
| Q2 2016 | $892,000 | +3.2% | 606,537 | +0.4% | 0.00% | – |
| Q1 2016 | $864,000 | -12.5% | 604,047 | +0.3% | 0.00% | – |
| Q4 2015 | $987,000 | -99.3% | 602,079 | -89.0% | 0.00% | -100.0% |
| Q3 2015 | $142,285,000 | +8882.6% | 5,472,350 | +843.6% | 0.01% | – |
| Q2 2015 | $1,584,000 | -22.4% | 579,973 | -4.8% | 0.00% | – |
| Q1 2015 | $2,042,000 | -3.3% | 609,463 | +0.2% | 0.00% | – |
| Q4 2014 | $2,111,000 | -29.7% | 608,306 | +2.0% | 0.00% | – |
| Q3 2014 | $3,001,000 | -56.7% | 596,623 | +19.0% | 0.00% | -100.0% |
| Q2 2014 | $6,924,000 | +2.4% | 501,365 | +13.5% | 0.00% | 0.0% |
| Q1 2014 | $6,764,000 | +172.3% | 441,769 | +43.7% | 0.00% | – |
| Q4 2013 | $2,484,000 | +55.2% | 307,404 | +91.4% | 0.00% | – |
| Q3 2013 | $1,601,000 | +330.4% | 160,591 | +83.5% | 0.00% | – |
| Q2 2013 | $372,000 | – | 87,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |